Yuya Sekine

Expansion of Cancer Risk Profile for <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants

Yukihide Momozawa, Rumi Sasai, Yoshiaki Usui et al. · JAMA Oncology · 2022 · 209 citations · Full text

Medicine, Genetics, Oncology +17

Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism

Mizuki Kobayashi, Kazuyuki Numakura, Shingo Hatakeyama et al. · Genes · 2022 · 39 citations · Full text

Medicine, Immunology, Oncology +17

Soil microbial response to experimental warming in cool temperate semi‐natural grassland in Japan

Shinpei Yoshitake, Nozomi Tabei, Yu Mizuno et al. · Ecological Research · 2014 · 17 citations

Agriculture, Ecology, Soil Sciences +16

Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma

Kazuyuki Numakura, Yuya Sekine, Shingo Hatakeyama et al. · Cancer Medicine · 2023 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Variant spectrum of von Hippel–Lindau disease and its genomic heterogeneity in Japan

Kenji Tamura, Yuki Kanazashi, Chiaki Kawada et al. · Human Molecular Genetics · 2023 · 11 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17